← Return to Ovarian carcinoma: Continue with Zejula (Niraparib) or not?

Discussion

Ovarian carcinoma: Continue with Zejula (Niraparib) or not?

Gynecologic Cancers | Last Active: Dec 12, 2023 | Replies (25)
Comment receiving replies
@crispin

Would like to continue Zejula after the 2 year mark (BRACA Mutation- Brip1); however, my oncologist refuses. She tells me that the risk of earlier death would be greater. The ovarian Association disagrees and tells me there is new research that it keeps helping. Can anyone weight in? Shouldn't it be my choice?

Jump to this post

Replies to "Would like to continue Zejula after the 2 year mark (BRACA Mutation- Brip1); however, my oncologist..."
jbickler | @jbickler | Dec 12, 2023

Hi Crispin, my oncologist and oncologist surgeon has said the same. I was told after the 2 yr period I must stop and more research has shown that the med can effect your bone marrow possibly getting bone marrow cancer. I was told by my Dr that there other treatments they can offer me if I have a recurrence which I gave not had any recurrence for almost 2 years. We will talk more when I see my oncologist in early January and we’ll go from there but if I have any problems before that appt we will meet sooner. So in the meantime I’m not going to give up Hope and keep my faith…❤️🙏🏻

VIEW AND REPLY